We have compiled the FY24 results of 90 Indonesian listed companies (~60% of JCI’s weight) and provide a bottom-up assessment to map company performances relative to Bloomberg consensus estimates. In conclusion, Indonesian companies posted relatively unexciting results, with revenue on average growing 6% y-y in FY24 (vs flat in FY23). Consolidated profit grew by 2% y-y (vs. -1% in FY23) – yet we think the relatively modest results have been priced in. We maintain our positive view on the market (see our report here).
For stock selection, with front-loaded risk and cheap valuation, we prefer high-beta, liquid, and fundamentally strong stocks that were previously beaten-down by market concerns. On tariff risks, we believe Indonesia is relatively better shielded compared to peers, due to relatively low export exposure. Our top picks are BMRI, BBNI, BRIS, MYOR, KLBF, and AMRT; in small caps, we prefer MIDI and CLEO.
Revenue and profit recap – pressure on margin continue
Revenues: Sectors among the highest revenue growth include properties (residential and industrial), logistics, retail, and healthcare. Banks consolidated net operating income grew +6.5% yoy, consumers at +4.9% yoy.
Net profit: Sectors that deliver strong net profit growth are logistics, poultry, CPO, and properties. Banks and consumers (ex-Unilever Indonesia [UNVR IJ, Reduce]) delivered 5% and 7% net profit growth, respectively – above the consolidated +2% profit growth.
We believe the slower profit growth relative to revenue indicates ongoing margin pressure, either from rising costs or deliberate margin sacrifices as companies prioritize market share and sales growth.
Outlook – slower growth in 1H25F
We see limited immediate catalysts for a pickup in purchasing power. The government’s focus on labor-intensive sectors lays the groundwork for a gradual recovery, in our view, though the impact may take time to materialize. We expect 1Q25F GDP to hover around 5%, supported by stronger trade balance, with upside if fiscal disbursements accelerate.
On tariff risks, we expect Indonesia to benefit from relocation and business reforms. Indonesia’s relatively lower trade balance with the US compared to peers enhances its positioning for more favorable tariff treatment. President Prabowo’s response in terms of business reforms may also eliminate non-tariff barriers for foreign businesses, concerns cited by the USTR.
We continue to favor high beta, liquid, beaten-down stocks that are fundamentally strong, and that offer limited downside risk (refer here for our assessment of big caps). We also find that most companies have limited exposure to the US market, suggesting minimal vulnerabilities to recent reciprocal tariffs (see our analysis here). Our top picks are BMRI, BRIS, KLBF, MYOR, and AMRT. In small caps, we prefer MIDI and CLEO.
Fig. 26: CPO quarterly revenue growth – healthy overall growth with TAPG and LSIP leading the sector
Source: Bloomberg Finance L.P., Verdhana research
Fig. 27: Industrial land quarterly revenue growth – led by SSIA and KIJA
Source: Bloomberg Finance L.P., Verdhana research
INVESTMENT RATINGS A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general.
GENERAL DISCLOSURE/DISCLAIMER This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).
This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.
The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.
This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.
ANALYST CERTIFICATION The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.
RESTRICTIONS ON DISTRIBUTION
By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations.